Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00102960
Protocol Section: NCT00102960
Start Identification Module Data
Brief Title: Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
Official Title: A Phase III Randomized Open-Label Trial to Evaluate Strategies for Providing Antiretroviral Therapy to Infants Shortly After Primary Infection in a Resource Poor Setting
Acronym: None
Organization: National Institute of Allergy and Infectious Diseases NIAID
Organization Class: NIH
Organization Study ID: CIPRA ZA 002
Secondary IDs
Secondary ID Type Domain Link
CIPRA-SA Project 2 OTHER CIPRA httpsreporternihgovquickSearch5R01AI062512-02
10404 REGISTRY None None
CHER REGISTRY None None
5R01AI062512-02 NIH None None
Start Status Module Data
Status Verified Date: 2021-10
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class: NIH
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload